Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yvonne Hagenlocher"'
Autor:
Anna Held, Stephan C. Bischoff, Sonja Gommeringer, Katharina Feilhauer, Jörg Köninger, Axel Lorentz, Yvonne Hagenlocher
Publikováno v:
European Journal of Nutrition. 58:1391-1401
Inflammatory bowel disease (IBD) shows increasing prevalence over the last years. We propose that anti-inflammatory plant substances could be used as additional or alternative agents with good compliance in prevention and/or therapy of IBD and its co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a741d3d2a96175e343828bb437914c19
https://doi.org/10.1007/s00394-018-1661-x
https://doi.org/10.1007/s00394-018-1661-x
Autor:
Yvonne Hagenlocher, Michael Haagenson, Alexander H. Schmidt, Jon J. van Rood, Emmanuelle Polge, Michael R. Verneris, Katharine C. Hsu, Camila J. Hernández-Frederick, Mohamad Mohty, Stephen R. Spellman, Stephanie J. Lee, Julia Pingel, Katharina Fleischhauer, Arnon Nagler, Tao Wang
Publikováno v:
Bone marrow transplantation. 54(6)
Hematological malignancies can be cured by unrelated donor allogeneic HSCT and outcomes are optimized by high-resolution HLA matching at HLA-A, -B, -C, -DRB1 and -DQB1 (10/10 match). If a 10/10 match is unavailable, 9/10 matches may be suitable. Feta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb2b0fe47ab53ca04dca6beb7406709
https://pubmed.ncbi.nlm.nih.gov/30279575
https://pubmed.ncbi.nlm.nih.gov/30279575
Autor:
Yuri Ioffe, Alexander H. Schmidt, Geoffrey A. Behrens, Jürgen Sauter, Beatrix Willburger, Yvonne Hagenlocher
Publikováno v:
Human immunology. 80(2)
A total of 1075 Russians from the Russian part of Karelia were genotyped at high-resolution for the human leukocyte antigen loci HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 using next generation sequencing methods. The haplotypic and allelic profiles as w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc1550fbb1c327ee284999c25b79b59
https://pubmed.ncbi.nlm.nih.gov/30391501
https://pubmed.ncbi.nlm.nih.gov/30391501
Autor:
Axel Lorentz, Yvonne Hagenlocher
Publikováno v:
Molecular Immunology. 63:25-31
In the past decades an increasing prevalence of allergic disorders was observed in industrialized countries. Thus, it is necessary to develop adequate therapeutic and preventive strategies. Many of the conservative strategies possess diverse harmful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a996eb9e8b0e763820536a4f5f298e36
https://doi.org/10.1016/j.molimm.2013.12.005
https://doi.org/10.1016/j.molimm.2013.12.005
Autor:
Yvonne, Hagenlocher, Sonja, Gommeringer, Anna, Held, Katharina, Feilhauer, Jörg, Köninger, Stephan C, Bischoff, Axel, Lorentz
Publikováno v:
European journal of nutrition. 58(4)
Inflammatory bowel disease (IBD) shows increasing prevalence over the last years. We propose that anti-inflammatory plant substances could be used as additional or alternative agents with good compliance in prevention and/or therapy of IBD and its co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9fd1feca310d3cd5441354634b938fa
https://pubmed.ncbi.nlm.nih.gov/29525889
https://pubmed.ncbi.nlm.nih.gov/29525889
Autor:
Michael W. Schäffer, Yvonne Hagenlocher, Axel Lorentz, Kristina Kießling, Stephan C. Bischoff
Publikováno v:
European Journal of Nutrition. 54:1297-1309
In terms of their involvement in allergic and inflammatory conditions, mast cells (MC) can be promising targets for medical agents in therapy. Because of their good compliance and effectiveness, phytochemicals are of great interest as new therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad368c84b0c59f01c36e90b4457fd3f6
https://doi.org/10.1007/s00394-014-0810-0
https://doi.org/10.1007/s00394-014-0810-0
Autor:
Michael W. Schäffer, Yvonne Hagenlocher, Ina Bergheim, Steffi Zacheja, Axel Lorentz, Stephan C. Bischoff
Publikováno v:
Allergy. 68:490-497
Background Mast cells (MC) are main effector cells of allergic and other inflammatory reactions; however, only a few anti-MC agents are available for therapy. It has been reported that cinnamon extract (CE) attenuates allergic symptoms by affecting i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f061fb52c99adc565b38a7431e2e4c
https://doi.org/10.1111/all.12122
https://doi.org/10.1111/all.12122
Autor:
Katharina Feilhauer, Stephan C. Bischoff, Michael W. Schäffer, Axel Lorentz, Yvonne Hagenlocher
Publikováno v:
European journal of nutrition. 56(4)
Allergic diseases with mast cells (MC) as main effector cells show an increased prevalence. MC also play an essential role in other inflammatory conditions. Therapeutical use of anti-inflammatory nutraceuticals directly targeting MC activation could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a7a5bee184141f6879d2ef2534b372
https://pubmed.ncbi.nlm.nih.gov/27021766
https://pubmed.ncbi.nlm.nih.gov/27021766
Publikováno v:
The Journal of nutritional biochemistry. 30
Inflammatory bowel disease (IBD) shows an increasing prevalence and harm in western countries. Conventional therapies are associated with bad compliance and adverse side effects. Natural substances like cinnamon extract (CE) could be an additional th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90af4b3af6054f435d80aaa8ef463e94
https://pubmed.ncbi.nlm.nih.gov/27012624
https://pubmed.ncbi.nlm.nih.gov/27012624
Autor:
Axel Lorentz, Stephan C. Bischoff, Mehtap Civelek, Sabrina Satzinger, Katharina Feilhauer, Jörg Köninger, Yvonne Hagenlocher
Publikováno v:
Molecular Nutrition & Food Research. 61:1601085
cope Intestinal fibrosis, a complication of inflammatory bowel disease, is currently being addressed by surgery alone, with no adequate alternative therapy available for patients. We propose that anti-inflammatory plant substances like cinnamon extra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65aeeac77cd964b67cf85b4aeff54c9e
https://doi.org/10.1002/mnfr.201601085
https://doi.org/10.1002/mnfr.201601085